Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunophenotype Characterization of Circulating and Tumor Infiltrating Immune Cells in Malignant Brain Tumors.

NCT05831631 is registered in ClinicalTrials.gov with Pietro Mortini, MD, Prof. as lead sponsor.

NCT NCT05831631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05831631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunophenotype Characterization of Circulating and Tumor Infiltrating Immune Cells in Malignant Brain Tumors.
Lead sponsor
Pietro Mortini, MD, Prof.
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2022
Completion date
August 1, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor - metastatic, brain tumor, primary